vs

Side-by-side financial comparison of CARRIAGE SERVICES INC (CSV) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.

CARRIAGE SERVICES INC is the larger business by last-quarter revenue ($105.5M vs $57.6M, roughly 1.8× Phathom Pharmaceuticals, Inc.). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs 8.0%). CARRIAGE SERVICES INC produced more free cash flow last quarter ($6.2M vs $-167.0M).

Jardine Cycle & Carriage Limited is the investment holding company of Jardines in Southeast Asia. It is currently 75% held by the conglomerate.

Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.

CSV vs PHAT — Head-to-Head

Bigger by revenue
CSV
CSV
1.8× larger
CSV
$105.5M
$57.6M
PHAT
Growing faster (revenue YoY)
PHAT
PHAT
+86.2% gap
PHAT
94.1%
8.0%
CSV
More free cash flow
CSV
CSV
$173.2M more FCF
CSV
$6.2M
$-167.0M
PHAT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CSV
CSV
PHAT
PHAT
Revenue
$105.5M
$57.6M
Net Profit
$12.3M
Gross Margin
34.8%
86.7%
Operating Margin
23.3%
Net Margin
11.6%
Revenue YoY
8.0%
94.1%
Net Profit YoY
24.5%
71.6%
EPS (diluted)
$0.76

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSV
CSV
PHAT
PHAT
Q4 25
$105.5M
$57.6M
Q3 25
$102.7M
$49.5M
Q2 25
$102.1M
$39.5M
Q1 25
$107.1M
$28.5M
Q4 24
$97.7M
$29.7M
Q3 24
$100.7M
$16.4M
Q2 24
$102.3M
$7.3M
Q1 24
$103.5M
Net Profit
CSV
CSV
PHAT
PHAT
Q4 25
$12.3M
Q3 25
$6.6M
$-30.0M
Q2 25
$11.7M
$-75.8M
Q1 25
$20.9M
$-94.3M
Q4 24
$9.9M
Q3 24
$9.9M
$-85.6M
Q2 24
$6.3M
$-91.4M
Q1 24
$7.0M
Gross Margin
CSV
CSV
PHAT
PHAT
Q4 25
34.8%
86.7%
Q3 25
35.3%
87.5%
Q2 25
35.2%
87.2%
Q1 25
35.3%
86.9%
Q4 24
34.4%
87.1%
Q3 24
35.2%
85.6%
Q2 24
36.2%
81.2%
Q1 24
36.0%
Operating Margin
CSV
CSV
PHAT
PHAT
Q4 25
23.3%
Q3 25
17.0%
-30.8%
Q2 25
23.5%
-151.7%
Q1 25
29.5%
-276.5%
Q4 24
21.6%
Q3 24
22.7%
-433.0%
Q2 24
18.0%
-1055.4%
Q1 24
18.8%
Net Margin
CSV
CSV
PHAT
PHAT
Q4 25
11.6%
Q3 25
6.4%
-60.5%
Q2 25
11.5%
-191.9%
Q1 25
19.5%
-330.7%
Q4 24
10.1%
Q3 24
9.8%
-523.3%
Q2 24
6.1%
-1248.6%
Q1 24
6.7%
EPS (diluted)
CSV
CSV
PHAT
PHAT
Q4 25
$0.76
Q3 25
$0.41
$-0.41
Q2 25
$0.74
$-1.05
Q1 25
$1.34
$-1.31
Q4 24
$0.62
Q3 24
$0.63
$-1.32
Q2 24
$0.40
$-1.56
Q1 24
$0.45

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSV
CSV
PHAT
PHAT
Cash + ST InvestmentsLiquidity on hand
$1.7M
$130.0M
Total DebtLower is stronger
$209.1M
Stockholders' EquityBook value
$254.8M
$-438.2M
Total Assets
$1.3B
$259.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSV
CSV
PHAT
PHAT
Q4 25
$1.7M
$130.0M
Q3 25
$1.2M
$135.2M
Q2 25
$1.4M
$149.6M
Q1 25
$4.6M
$212.3M
Q4 24
$1.2M
$297.3M
Q3 24
$1.3M
$334.7M
Q2 24
$1.5M
$276.2M
Q1 24
$1.7M
Total Debt
CSV
CSV
PHAT
PHAT
Q4 25
$209.1M
Q3 25
$207.1M
Q2 25
$205.1M
Q1 25
$203.2M
Q4 24
$201.4M
Q3 24
$175.7M
Q2 24
$174.4M
Q1 24
Stockholders' Equity
CSV
CSV
PHAT
PHAT
Q4 25
$254.8M
$-438.2M
Q3 25
$242.1M
$-422.5M
Q2 25
$235.4M
$-405.8M
Q1 25
$223.1M
$-338.4M
Q4 24
$208.6M
$-253.6M
Q3 24
$198.1M
$-187.1M
Q2 24
$187.9M
$-233.8M
Q1 24
$179.6M
Total Assets
CSV
CSV
PHAT
PHAT
Q4 25
$1.3B
$259.1M
Q3 25
$1.3B
$240.3M
Q2 25
$1.3B
$250.2M
Q1 25
$1.3B
$294.2M
Q4 24
$1.3B
$378.3M
Q3 24
$1.3B
$387.0M
Q2 24
$1.3B
$319.4M
Q1 24
$1.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSV
CSV
PHAT
PHAT
Operating Cash FlowLast quarter
$14.1M
$-166.8M
Free Cash FlowOCF − Capex
$6.2M
$-167.0M
FCF MarginFCF / Revenue
5.9%
-290.0%
Capex IntensityCapex / Revenue
7.5%
0.4%
Cash ConversionOCF / Net Profit
1.15×
TTM Free Cash FlowTrailing 4 quarters
$40.1M
$-328.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSV
CSV
PHAT
PHAT
Q4 25
$14.1M
$-166.8M
Q3 25
$24.7M
$-14.1M
Q2 25
$8.1M
$-62.7M
Q1 25
$13.8M
$-84.9M
Q4 24
$9.3M
$-266.8M
Q3 24
$20.9M
$-63.6M
Q2 24
$2.2M
$-70.7M
Q1 24
$19.7M
Free Cash Flow
CSV
CSV
PHAT
PHAT
Q4 25
$6.2M
$-167.0M
Q3 25
$18.0M
$-14.1M
Q2 25
$5.2M
$-62.8M
Q1 25
$10.6M
$-84.9M
Q4 24
$4.9M
$-266.9M
Q3 24
$16.2M
$-63.6M
Q2 24
$-1.4M
$-70.8M
Q1 24
$16.2M
FCF Margin
CSV
CSV
PHAT
PHAT
Q4 25
5.9%
-290.0%
Q3 25
17.5%
-28.6%
Q2 25
5.1%
-159.0%
Q1 25
9.9%
-297.9%
Q4 24
5.0%
-899.8%
Q3 24
16.1%
-389.0%
Q2 24
-1.4%
-966.2%
Q1 24
15.6%
Capex Intensity
CSV
CSV
PHAT
PHAT
Q4 25
7.5%
0.4%
Q3 25
6.5%
0.1%
Q2 25
2.8%
0.2%
Q1 25
3.0%
0.1%
Q4 24
4.5%
0.5%
Q3 24
4.6%
0.3%
Q2 24
3.5%
0.6%
Q1 24
3.4%
Cash Conversion
CSV
CSV
PHAT
PHAT
Q4 25
1.15×
Q3 25
3.76×
Q2 25
0.69×
Q1 25
0.66×
Q4 24
0.94×
Q3 24
2.11×
Q2 24
0.34×
Q1 24
2.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSV
CSV

Propertyand Merchandise$47.8M45%
Cemetery Interment Rights$24.8M23%
Merchandise$18.9M18%
Other Revenue$10.2M10%
Other$3.9M4%

PHAT
PHAT

Segment breakdown not available.

Related Comparisons